Clinical Trial Update: Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial [Phase 2]

View source ↗

Summary

This clinical trial update describes the Phase 2 DIRECT trial evaluating whether FDG-PET/CT imaging before surgery can predict response to therapy in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING